{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:06:26Z","timestamp":1792523186043,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1756-0500-7-796","type":"journal-article","created":{"date-parts":[[2014,11,15]],"date-time":"2014-11-15T01:50:24Z","timestamp":1416016224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["From prescriptions to drug use periods - things to notice"],"prefix":"10.1186","volume":"7","author":[{"given":"Antti","family":"Tanskanen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Taipale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjaana","family":"Koponen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maija","family":"Tolppanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirpa","family":"Hartikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riitta","family":"Ahonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Tiihonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,14]]},"reference":[{"key":"3319_CR1","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0895-4356(96)00267-3","volume":"49","author":"J Martikainen","year":"1996","unstructured":"Martikainen J, Klaukka T, Reunanen A, Peura S, Wahlroos H: Recent trends in the consumption of lipid-lowering drugs in Finland. J Clin Epidemiol. 1996, 49: 1453-1457. 10.1016\/S0895-4356(96)00267-3.","journal-title":"J Clin Epidemiol"},{"key":"3319_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1034\/j.1600-0447.2000.102002126.x","volume":"102","author":"UA Andersen","year":"2000","unstructured":"Andersen UA, Andersen M, Rosholm JU, Gram LF: Contacts to the health care system prior to suicide: a comprehensive analysis using registers for general and psychiatric hospital admissions, contacts to general practitioners and practising specialists and drug prescriptions. Acta Psychiatr Scand. 2000, 102: 126-134. 10.1034\/j.1600-0447.2000.102002126.x.","journal-title":"Acta Psychiatr Scand"},{"key":"3319_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/CLEP.S13458","volume":"2","author":"V Ehrenstein","year":"2010","unstructured":"Ehrenstein V, Antonsen S, Pedersen L: Existing data sources for clinical epidemiology: Aarhus University Prescription Database. Clin Epidemiol. 2010, 2: 273-279.","journal-title":"Clin Epidemiol"},{"key":"3319_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00228-003-0635-x","volume":"59","author":"A Helin-Salmivaara","year":"2003","unstructured":"Helin-Salmivaara A, Klaukka T, Huupponen R: Heavy users of non-steroidal anti-inflammatory drugs: a nationwide prescription database study in Finland. Eur J Clin Pharmacol. 2003, 59: 477-482. 10.1007\/s00228-003-0635-x.","journal-title":"Eur J Clin Pharmacol"},{"key":"3319_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3109\/02813438709018100","volume":"5","author":"F Rasmussen","year":"1987","unstructured":"Rasmussen F, Smedby B: Physician visits and prescribed drugs among young children and their mothers. Scand J Prim Health Care. 1987, 5: 225-231. 10.3109\/02813438709018100.","journal-title":"Scand J Prim Health Care"},{"key":"3319_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/BF00315471","volume":"44","author":"A Ekedahl","year":"1993","unstructured":"Ekedahl A, Lidbeck J, Lithman T, Noreen D, Melander A: Benzodiazepine prescribing patterns in a high-prescribing Scandinavian community. Eur J Clin Pharmacol. 1993, 44: 141-146. 10.1007\/BF00315471.","journal-title":"Eur J Clin Pharmacol"},{"key":"3319_CR7","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/pds.3457","volume":"22","author":"B Wettermark","year":"2013","unstructured":"Wettermark B, Zo\u00ebga H, Furu K, Korhonen M, Hallas J, N\u00f8rgaard M, Almarsdottir AB, Andersen M, Anderson Sundell K, Bergman U, Helin-Salmivaara A, Hoffmann M, Kieler H, Martikainen JE, Mortensen M, Petzold M, Wallach-Kildermoes H, Wallin C, S\u00f8rensen HT: The Nordic prescription databases as a resource for pharmacoepidemiological research \u2013 a literature review. Pharmacoepidemiol Drug Saf. 2013, 22: 691-699. 10.1002\/pds.3457.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3319_CR8","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/00005650-198808000-00007","volume":"26","author":"JF Steiner","year":"1988","unstructured":"Steiner JF, Koepsell TD, Fihn SD, Inui TS: A general method of compliance assessment using centralized pharmacy records. Med Care. 1988, 26: 814-823. 10.1097\/00005650-198808000-00007.","journal-title":"Med Care"},{"key":"3319_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0895-4356(96)00268-5","volume":"50","author":"JF Steiner","year":"1997","unstructured":"Steiner JF, Prochazka AV: The assessment of refill compliance using pharmacy records: methods, validity and applications. J Clin Epidemiol. 1997, 50: 105-116. 10.1016\/S0895-4356(96)00268-5.","journal-title":"J Clin Epidemiol"},{"key":"3319_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1742-7843.2009.00494.x","volume":"106","author":"K Furu","year":"2010","unstructured":"Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, S\u00f8rensen HT: The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol. 2010, 106: 86-94. 10.1111\/j.1742-7843.2009.00494.x.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"3319_CR11","volume-title":"DDD, Definition and General Considerations","author":"WHO","year":"2013","unstructured":"WHO: DDD, Definition and General Considerations. 2013, \n                    http:\/\/www.whocc.no\/ddd\/definition_and_general_considera\/\n                    \n                   Accessed November 1st"},{"key":"3319_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2147\/CLEP.S46622","volume":"5","author":"AM Tolppanen","year":"2013","unstructured":"Tolppanen AM, Taipale H, Koponen M, Lavikainen P, Tanskanen A, Tiihonen J, Hartikainen S: Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer\u2019s disease research \u2013 the Medication use among persons with Alzheimer\u2019s disease (MEDALZ-2005) study. Clin Epidemiol. 2013, 5: 277-284.","journal-title":"Clin Epidemiol"},{"key":"3319_CR13","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1007\/s00228-014-1684-z","volume":"70","author":"MS Bakken","year":"2014","unstructured":"Bakken MS, Engeland A, Enges\u00e6ter LB, Ranhoff AH, Hunskaar S, Ruths S: Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study. Eur J Clin Pharmacol. 2014, 70: 1972-1979.","journal-title":"Eur J Clin Pharmacol"},{"key":"3319_CR14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/2193-1801-3-282","volume":"3","author":"A Kemp","year":"2014","unstructured":"Kemp A, Preen DB, Saunders C, Boyle F, Bulsara M, Malacova E, Roughead EE: Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice?. Springerplus. 2014, 3: 282-10.1186\/2193-1801-3-282. doi:10.1186\/2193-1801-3-282","journal-title":"Springerplus"},{"key":"3319_CR15","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/ejhf.81","volume":"16","author":"R B\u00f8lling","year":"2014","unstructured":"B\u00f8lling R, Scheller NM, K\u00f8ber L, Poulsen HE, Gislason GH, Torp\u2012Pedersen C: Comparison of the clinical outcome of different beta\u2012blockers in heart failure patients: a retrospective nationwide cohort study. Eur J Heart Fail. 2014, 16: 678-684. 10.1002\/ejhf.81.","journal-title":"Eur J Heart Fail"},{"key":"3319_CR16","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/pds.1230","volume":"15","author":"SE Andrade","year":"2006","unstructured":"Andrade SE, Kahler KH, Frech F, Chan KA: Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006, 15: 565-574. 10.1002\/pds.1230.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3319_CR17","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/pds.3567","volume":"23","author":"G Ringb\u00e4ck Weitoft","year":"2014","unstructured":"Ringb\u00e4ck Weitoft G, Berglund M, Lindstr\u00f6m EA, Nilsson M, Salmi P, Ros\u00e9n M: Mortality, attempted suicide, re-hospitalisation and prescription refill for clozapine and other antipsychotics in Sweden-a register-based study. Pharmacoepidemiol Drug Saf. 2014, 23: 290-298. 10.1002\/pds.3567.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3319_CR18","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/pds.1549","volume":"17","author":"LH Nielsen","year":"2008","unstructured":"Nielsen LH, L\u00f8kkegaard E, Andreasen AH, Keiding N: Using prescription registries to define continuous drug use: how to fill gaps between prescriptions. Pharmacoepidemiol Drug Saf. 2008, 17: 384-388. 10.1002\/pds.1549.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3319_CR19","volume-title":"General information of Nordic Article number","author":"Pharmaceutical Information Center","year":"2013","unstructured":"Pharmaceutical Information Center: General information of Nordic Article number. 2013, wiki.vnr.fi.. Accessed November 1st"},{"key":"3319_CR20","volume-title":"BMJ","author":"IJ Douglas","year":"2008","unstructured":"Douglas IJ, Smeeth L: Exposure to antipsychotics and risk of stroke: self controlled case series study. BMJ. 2008, doi:10.1136\/bmj.a1227"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-7-796.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T03:48:41Z","timestamp":1548215321000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-7-796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,14]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3319"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-7-796","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,14]]},"assertion":[{"value":"30 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"796"}}